Nanobiotix (NBTX) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free NBTX Stock Alerts $5.90 +0.19 (+3.33%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Resultsglobenewswire.com - April 24 at 4:40 PMNANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024globenewswire.com - April 17 at 4:15 PMBaillie Gifford & Co. Has $20.89 Million Stock Holdings in Nanobiotix S.A. (NASDAQ:NBTX)marketbeat.com - April 11 at 7:23 AMNanobiotix (NASDAQ:NBTX) Trading Down 1.6%marketbeat.com - April 3 at 2:15 AMNanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiationglobenewswire.com - April 2 at 4:15 PMNanobiotix to Present at Upcoming Investor Conferences in Marchglobenewswire.com - March 6 at 4:15 PMNanobiotix S.A. (NASDAQ:NBTX) Shares Bought by Baillie Gifford & Co.marketbeat.com - February 17 at 9:19 AMJohnson & Johnson Buys Shares of 959,637 Nanobiotix S.A. (NASDAQ:NBTX)marketbeat.com - February 12 at 4:36 PMNanobiotix (NASDAQ:NBTX) Shares Down 2.3% marketbeat.com - February 3 at 2:10 AMNanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 5:38 PMNanobiotix S.A.: Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Studyfinanznachrichten.de - January 30 at 9:03 AMNanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Studyfinance.yahoo.com - January 29 at 7:29 PMNBTX Nanobiotix S.A.seekingalpha.com - January 18 at 3:42 PMNanobiotix S.A. (NASDAQ:NBTX) Sees Large Increase in Short Interestmarketbeat.com - January 12 at 4:52 PMNanobiotix initiated with an Outperform at Leerinkrealmoney.thestreet.com - December 8 at 6:54 PMNanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.finance.yahoo.com - December 4 at 6:46 PMNanobiotix S.A.: NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Updatefinanznachrichten.de - November 15 at 2:59 AMNANOBIOTIX Provides Third Quarter 2023 Operational and Financial Updatefinance.yahoo.com - November 13 at 8:48 PMNANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023finance.yahoo.com - November 9 at 6:12 PMNanobiotix S.A.: Voting Rights and Shares Capital of the Companyfinanznachrichten.de - November 9 at 8:11 AMNANOBIOTIX Announces Closing of Global Offeringfinance.yahoo.com - November 7 at 8:28 PMNANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6Mfinance.yahoo.com - November 6 at 8:16 AMWhy Nanobiotix (NBTX) Stock Is Plunging Thursdaymsn.com - November 2 at 1:37 PMNANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55Mfinance.yahoo.com - November 2 at 1:37 PMNanobiotix SA ADR NBTXmorningstar.com - November 2 at 12:47 AMNANOBIOTIX Announces Launch of Global Follow-On Offering and a Concurrent Private Placement Along with the Removal of the EIB Cash Covenantfinance.yahoo.com - November 1 at 7:46 PMNANOBIOTIX Announces Updated Preliminary Results From Phase 1 Pancreatic Cancer Trial and New Exploratory Analysis From Completed Phase 1 Head and Neck Cancer Trial at ESMO 2023finance.yahoo.com - October 23 at 6:11 AMNanobiotix falls after Phase 1 data for lead asset in head and neck cancermsn.com - October 5 at 11:53 AMUBS Reaffirms Their Buy Rating on Nanobiotix (NBTX)markets.businessinsider.com - October 5 at 6:53 AMNanobiotix Announces the Presentation of the Final Efficacy Analysis From Phase 1 Cohort Expansion Evaluating NBTXR3 in Locally Advanced Head and Neck Cancer Showing Median Progression-Free Survival of 16.9 Months and Median Overall Survival of 23.1 Monthsfinance.yahoo.com - October 4 at 5:30 PMNANOBIOTIX Announces Oral Presentation of Final Results From a Phase 1 Dose Expansion Study Evaluating NBTXR3 in Head and Neck Cancer at the 65th Annual Meeting of the American Society for Radiation Oncologyfinance.yahoo.com - September 29 at 4:55 PMNANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancerfinance.yahoo.com - September 28 at 5:01 PMNanobiotix S.A.: NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023finanznachrichten.de - September 27 at 3:23 PMNANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023finance.yahoo.com - September 26 at 6:12 PMNanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023finance.yahoo.com - September 19 at 7:04 PMNANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officerfinance.yahoo.com - September 5 at 4:27 PMNANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 31 at 7:15 PMNanobiotix: At A Crucial Juncture For Dataseekingalpha.com - August 25 at 7:51 AMNANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3finance.yahoo.com - August 15 at 5:21 PMNANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023finance.yahoo.com - August 4 at 5:54 PMNanobiotix Shares Rise 9% After Phase 1/2 Study for NBTXR3 Beginsmarketwatch.com - July 20 at 12:26 PMNANOBIOTIX Announces First Patient Injected in New Phase 1/2 Study Evaluating Radiotherapy-Activated NBTXR3 Plus Anti-PD-1 for Patients With Advanced Cancersfinance.yahoo.com - July 19 at 8:06 PMNBTX Soars On Teaming Up with Janssen for NBTXR3msn.com - July 11 at 8:29 PMWhy Nanobiotix Stock Is Soaring Mondaybenzinga.com - July 10 at 2:48 PMBiggest stock movers today: Icahn Enterprises, Nanobiotix and moremsn.com - July 10 at 8:14 AMNanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Marketmarkets.businessinsider.com - July 10 at 8:14 AMNanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTXmarketwatch.com - July 10 at 8:14 AMNanobiotix up 54% on licensing agreement for development of Radioenhancer NBTXR3msn.com - July 10 at 8:14 AMNANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3finance.yahoo.com - July 10 at 8:14 AMNanobiotix: A Promising Cancer Treatment But A Risky Investment For Nowmsn.com - June 6 at 8:35 AM Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 NBTX Media Mentions By Week NBTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBTX News Sentiment▼0.000.43▲Average Medical News Sentiment NBTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBTX Articles This Week▼11▲NBTX Articles Average Week Get Nanobiotix News Delivered to You Automatically Sign up to receive the latest news and ratings for NBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AEON Biopharma News Today Foghorn Therapeutics News Today Xeris Biopharma News Today Prelude Therapeutics News Today 2seventy bio News Today Telomir Pharmaceuticals News Today Pyxis Oncology News Today XBiotech News Today Nektar Therapeutics News Today Puma Biotechnology News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBTX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
